Andon Health (002432.SZ) plans to spend 300 million to 600 million yuan on share buybacks.

Andon Health (002432.SZ) announcement: The company plans to use its own funds and funds from a special repurchase loan to repurchase a portion of the company's publicly traded shares through centralized bidding in the secondary market. The total amount of funds for this repurchase shall be no less than 300 million yuan (inclusive) and no more than 600 million yuan (inclusive). The repurchase price for the shares shall not exceed 53.5 yuan per share (inclusive). The repurchase of shares is intended to maintain the company's value and shareholder interests. The repurchase scheme is within the authority of the board of directors and does not require approval from a shareholders' meeting. The implementation period for the repurchase shall not exceed 3 months from the date of approval of the final repurchase scheme by the company's board of directors. As of the date of this announcement, the company has obtained a "Loan Commitment Letter" from the Tianjin Branch of Shanghai Pudong Development Bank Limited, pledging a special repurchase loan amount not exceeding 500 million yuan, and not exceeding 90% of the total amount of the repurchase transaction. The loan period shall not exceed 36 months.